L3Harris Technologies vs Northrop Grumman
LHX and NOC side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LHX and NOC compare
Northrop Grumman is the larger company, worth 1.6 times as much as L3Harris Technologies ($78.6B against $48.5B).
On earnings, Northrop Grumman is cheaper: it trades at 17.5× trailing earnings, against 24.3× for L3Harris Technologies.
Northrop Grumman grew revenue faster over the last twelve months (6.5% versus 5.3% for L3Harris Technologies).
Northrop Grumman keeps more of each dollar of sales as profit, with a net margin of 10.4% compared with 5.2% at L3Harris Technologies.
Both pay dividends: L3Harris Technologies yields 1.4% and Northrop Grumman 1.7%.
L3Harris Technologies scores higher on the StockData Score (19 against 18 for Northrop Grumman), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LHX | NOC |
|---|---|---|
| Size and price | ||
| Market cap | $48.5B | $78.6B |
| Share price | $260.74 | $553.26 |
| Change, 1 year | −9.9% | −0.85% |
| Change, 5 years | 21.2% | 56.3% |
| Beta (5Y) | 0.45 | 0.43 |
| Employees | 45K | 95K |
| StockData Score | ||
| Total score | 19 (better) | 18 |
| Valuation score | 6 (better) | 3 |
| Growth score | 3 (better) | 2 |
| Performance score | 3 | 5 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 24.3× | 17.5× (better) |
| P/S | 1.2× (better) | 1.8× |
| P/B | 2.4× (better) | 4.2× |
| EV/EBITDA | 10.6× (better) | 14.6× |
| P/FCF | 13.3× (better) | 20.5× |
| PEG | 1.54 | – |
| FCF yield | 7.5% (better) | 4.9% |
| Fair value | $357.80 | $649.75 |
| Margin of safety | 27.1% (better) | 14.9% |
| Growth | ||
| Revenue growth (TTM) | 5.3% | 6.5% (better) |
| Revenue growth, 5Y average | – | 2.7% |
| Net income growth (TTM) | 16.2% (better) | 12.5% |
| EPS growth (TTM) | 15.1% (better) | 14.0% |
| EPS growth, 5Y average | 1.6% | 8.9% (better) |
| Profitability | ||
| Gross margin | 25.6% | – |
| Operating margin | 10.6% (better) | 10.6% |
| Net margin | 5.2% | 10.4% (better) |
| FCF margin | 9.2% (better) | 8.8% |
| Return on equity | 10.3% | 26.1% (better) |
| Return on invested capital | 12.8% | 13.3% (better) |
| Financial health | ||
| Debt / equity | 0.54 (better) | 0.81 |
| Net debt / EBITDA | 1.49 (better) | 1.86 |
| Current ratio | 1.20 | 1.23 (better) |
| Altman Z-score | 2.72 | 3.09 (better) |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | 1.7% (better) |
| Payout ratio | 45.5% | 30.2% |
| Years of dividend growth | 4 | 16 (better) |
| Dividend growth, 5Y average | – | 9.7% |
| Buyback yield | 1.6% (better) | 0.67% |
| Shareholder yield | 3.0% (better) | 2.4% |
| Ownership | ||
| Held by institutions | 87.9% | 83.5% |
| Held by insiders | 0.32% | 0.22% |
| Insider net buying, 12 months | −$7.5M (better) | −$26.4M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 2.2% | 1.5% |
Go deeper
- LHX stock overview
- LHX income statement
- LHX valuation and score
- NOC stock overview
- NOC income statement
- NOC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.